Yuhe Liu – Trademark Portfolio

Entity Type: 01

Yuhe Liu owns a portfolio of 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), including well-known marks such as LIKEFOND, LIKEMATE, and LIKEMUSE. Of these, 3 are registered and 2 are pending. The portfolio spans 3 Nice Classification classes, led by Class 3 (Cosmetics & Cleaning) and Class 10 (Medical Apparatus). Headquartered in Jinan City.

No. 204, Huangluxian Village, Zhonggong Town, Licheng District

Jinan City 250103 , CN

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

Yuhe Liu's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

3
Cosmetics & Cleaning (2 filings)

Bleaching preparations and other substances for laundry use; cleaning, polishing, scouring

10
Medical Apparatus (2 filings)

Surgical, medical, dental and veterinary apparatus and instruments

17
Rubber Goods (1 filing)

Unprocessed and semi-processed rubber, gutta-percha, gum, asbestos, mica

Frequently Asked Questions

How many trademarks does Yuhe Liu have?

Yuhe Liu has 5 U.S. trademarks filed with the USPTO. Of these, 3 registered, 2 pending.

What trademark classes does Yuhe Liu file in?

Yuhe Liu files trademarks across 3 Nice Classification classes. The most active classes are Class 3 (Cosmetics & Cleaning), Class 10 (Medical Apparatus), Class 17 (Rubber Goods). Class 3 covers bleaching preparations and other substances for laundry use; cleaning, polishing, scouring.

What are Yuhe Liu's most well-known trademarks?

Yuhe Liu's registered trademark portfolio includes well-known marks such as LIKEFOND, LIKEMATE, and LIKEMUSE. These are among 3 currently registered trademarks in the portfolio.

What is Yuhe Liu's trademark registration success rate?

Yuhe Liu has a 100% trademark registration rate, with 3 out of 3 resolved applications resulting in successful registration. Currently, 2 applications are pending review.